Status:

COMPLETED

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Post-Traumatic Stress Disorders

Eligibility:

All Genders

18-64 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to obtain data investigating the safety and efficacy of eszopiclone for the treatment of post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of ...

Detailed Description

Post-traumatic stress disorder (PTSD) is characterized by three symptom groupings: re-experiencing symptoms including flashbacks, nightmares, and intrusive memories; physiological hyperarousal; and av...

Eligibility Criteria

Inclusion

  • Male or female outpatients 18-64 years of age with a primary diagnosis of PTSD as defined by DSM-IV criteria with associated sleep disturbance

Exclusion

  • Pregnant women, lactating women, and women of childbearing potential who are not using medically accepted forms of contraception.
  • Concurrent use of other psychotropic medications, other than antidepressants at stable dose for at least 4 weeks prior to randomization
  • Serious medical illness or instability
  • Seizure disorders with the exception of a history of febrile seizures if they occurred during childhood
  • Concurrent psychotherapy initiated within one month of randomization or ongoing psychotherapy of any duration directed specifically toward treatment of PTSD and/or sleep disturbance
  • Diagnosis of schizophrenia, mental retardation, OCD, organic medical disorders or bipolar disorder, eating disorders in the past 6 months, alcohol or substance abuse in the past 3 months, or dependence within the past 6 months.
  • Patients with significant suicidal ideation or who have enacted suicidal behaviors within 6 months prior to intake

Key Trial Info

Start Date :

June 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2008

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT00120250

Start Date

June 1 2005

End Date

June 1 2008

Last Update

April 26 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114